2-47478312-G-C
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PS1PM2PP3_StrongPP5_Very_Strong
The NM_000251.3(MSH2):c.2251G>C(p.Gly751Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★★). Another nucleotide change resulting in same amino acid change has been previously reported as Pathogenicin Lovd.
Frequency
Consequence
NM_000251.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSH2 | NM_000251.3 | c.2251G>C | p.Gly751Arg | missense_variant | 14/16 | ENST00000233146.7 | NP_000242.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSH2 | ENST00000233146.7 | c.2251G>C | p.Gly751Arg | missense_variant | 14/16 | 1 | NM_000251.3 | ENSP00000233146.2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Lynch syndrome 1 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Aug 08, 2023 | This variant is considered likely pathogenic. This variant is strongly associated with more severe personal and family histories of cancer, typical for individuals with pathogenic variants in this gene [PMID: 27363726]. - |
Likely pathogenic, reviewed by expert panel | curation | International Society for Gastrointestinal Hereditary Tumours (InSiGHT) | Jun 13, 2018 | Same amino acid change as pathogenic variant - |
Hereditary cancer-predisposing syndrome Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Jan 02, 2022 | This missense variant (c.2215G>T, p.Gly751Arg) replaces glycine with arginine at codon 751 in the MutL interaction of the MSH2 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). This variant has been reported in individuals affected with colorectal cancer with tumors showing microsatellite instability (PMID: 24278394, 26096739). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). A different nucleotide change with the same protein consequence, c.2251G>A (p.Gly751Arg), is known to result in loss of MSH2 protein function and cause Lynch syndrome (ClinVar variation ID:90943). Based on the available evidence, this c.2215G>T (p.Gly751Arg) variant is classified as Likely Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 30, 2022 | The p.G751R pathogenic mutation (also known as c.2251G>C), located in coding exon 14 of the MSH2 gene, results from a G to C substitution at nucleotide position 2251. The glycine at codon 751 is replaced by arginine, an amino acid with dissimilar properties. This alteration has been identified in multiple individuals with Lynch syndrome-related cancers, including families meeting Amsterdam criteria and individuals with tumor testing data highly suggestive of Lynch syndrome (Lucci-Cordisco E et al. Cancer Biomark. 2006;2(1-2):11-27; De Lellis L et al. PLoS ONE 2013 Nov;8(11):e81194; Duraturo F et al. Int. J. Mol. Med. 2015 Aug;36(2):511-7; Ambry internal data). Additionally, functional studies using a yeast-based assay have shown deficient protein function for p.G751R compared to wild-type (Gammie AE et al. Genetics. 2007 Oct;177(2):707-21). In a massively parallel cell-based functional assay testing susceptibility to a DNA damaging agent, 6-thioguanine (6-TG), this variant was reported to be functionally deleterious (Jia X et al. Am J Hum Genet. 2021 01;108:163-175). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Feb 28, 2020 | Not found in the total gnomAD dataset, and the data is high quality. Inconclusive segregation with disease. Predicted to have a damaging effect on the protein. Located in potentially critical domain of the protein. Assessment of experimental evidence suggests this variant results in abnormal protein function. - |
Hereditary nonpolyposis colorectal neoplasms Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 14, 2023 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this missense change affects MSH2 function (PMID: 17720936, 26951660, 31237724). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (PMID: 33357406) indicates that this missense variant is expected to disrupt MSH2 function. This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 751 of the MSH2 protein (p.Gly751Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of Lynch syndrome (PMID: 10530344, 10732761, 23990280, 25430799, 31118792, 31615790; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 439192). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at